DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

HORSE CHESTNUT

Search structure
Synonyms:
Aescorin
Aesculi semen
Aesculus hippocastanum
Aesculus hippocastanum dry extract
Aesculus hippocastanum extract
Aesculus hippocastanum fruit
Aesculus hippocastanum l. seed
Aesculus hippocastanum nut
Aesculus hippocastanum seed
Aesculus hippocastanum seed dry extract
Aesculus hippocastanum seed extract
Aesculus hippocastanum whole
Aescusan
Buckeye seed
Common horse chestnut nut
Essaven
European horse chestnut nut
Hippocastani semen
Horse chestnut
Horse-chestnut
Horse chestnut dried extract
Horse chestnut nut
Horse chestnut seed
Horse-chestnut seed
Horse chestnut whole
Suo luo zi
Venalot
Venoplant
Venopyronum
Venostasin
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 3C18L6RJAZ

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphedema 2 D008209 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109073
FDA SRS 3C18L6RJAZ
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70